Sign Up to like & get
recommendations!
0
Published in 2021 at "Naunyn-Schmiedeberg's archives of pharmacology"
DOI: 10.1007/s00210-021-02162-7
Abstract: PURPOSE Antagonising serotonin (5-HT) type 2A receptors (5-HT2AR) is an effective strategy to alleviate both dyskinesia and psychosis in Parkinson's disease (PD). We have recently shown that activation of metabotropic glutamate 2 receptors (mGluR2), via…
read more here.
Keywords:
ht2ar antagonism;
emd 281;
mglur2;
dyskinesia psychosis ... See more keywords